RecruitingDrug trialVA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDSThe goal of this phase 1/2 trial is to test the safety and efficacy of Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT in treating patients with higher-risk MDS.